Hydroxychloroquine reduces T cells activation recall antigen responses

BACKGROUND: In the context of the current COVID-19 pandemic, there is still limited information about how people suffering from autoimmune diseases respond to the different COVID vaccines. The fact that they are taking an immunosuppressant or other drugs that aim to decrease the immune system activi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kowatsch, Monika M., Lajoie, Julie, Mwangi, Lucy, Omollo, Kenneth, Oyugi, Julius, Hollett, Natasha, Kimani, Joshua, Fowke, Keith R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395872/
https://www.ncbi.nlm.nih.gov/pubmed/37531383
http://dx.doi.org/10.1371/journal.pone.0287738

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395872/
https://www.ncbi.nlm.nih.gov/pubmed/37531383
http://dx.doi.org/10.1371/journal.pone.0287738

Ejemplares similares